While the BSE small-cap index slipped four per cent on Tuesday, the mid-cap index lost 3.4 per cent, compared with the 1.2 per cent decline in the Sensex. On the National Stock Exchange, the mid-cap and small-cap indices ended four per cent lower each.
The fall in the overall markets comes ahead of a US Federal Reserve meeting in which analysts say Fed chair Janet Yellen might provide cues on a rate increase.
“The benchmark indices have been correcting since the past few days and we have seen some selling by foreign institutional investors in the futures and options segment. Against this backdrop, mid- and small-caps were outperforming, and have seen a healthy gain. Therefore, a correction was imminent,” said Sunil Jain, head of retail research, Nirmal Bang.
Among small-caps, Venus Remedies, NDTV, Nucleus Software Exports, Onmobile Global, Dhunseri Petrochem & Tea and Himachal Futuristic Communications declined more than 10 per cent each on Tuesday, while in the mid-cap segment, HDIL, GSFC, Delta Corp, Gujarat Pipavav Port, Amtek India and Arvind fell up to 20 per cent each.
Though the markets have lost ground since the past few sessions, analysts do not seem worried. They suggest the long-term market story remains intact structurally. However, expect stocks in the mid- and small -cap segments to see more correction, given the recent rally.
R Sreesankar, head of institutional equities, Prabhudas Lilladher, says: “This is a normal correction in the mid-cap segment, as the stocks had run up sharply. There is nothing to be worried about.”
Jain of Nirmal Bang says for those seeking to buy mid- and small-caps from a two-year perspective, the best strategy is to wait, as these stocks could be available cheaper and at compelling valuations. His top picks in this space are Dolpin Offshore, Dishman Pharma and Indoco Remidies. He suggests those with a long-term perspective buy these at lower levels.
Rikesh Parikh, vice–president (equities), Motilal Oswal Securities, says investors shouldn’t expect an immediate turnaround in these stocks, as these are likely to consolidate around current levels, before resuming their upward march.
| MIDCAP MAYHEM | |||
| 15 Sep 14 | 16 Sep 14 | % chg | |
| GMR Infra | 24.85 | 22.30 | -10.3 |
| GSFC | 107.55 | 96.95 | -9.9 |
| Amtek India | 115.55 | 104.50 | -9.6 |
| Delta Corp | 95.55 | 87.35 | -8.6 |
| Arvind | 333.95 | 305.40 | -8.5 |
| HDIL | 94.05 | 86.50 | -8.0 |
| Symphony | 1445.60 | 1330.00 | -8.0 |
| Gujarat Pipavav | 177.35 | 163.25 | -8.0 |
| Jain Irrigation | 95.05 | 87.55 | -7.9 |
| Dalmia Bharat | 459.55 | 426.00 | -7.3 |
| Share price on BSE in Rs | |||
| Data compiled by BS Research | |||
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)